Zensar Technologies, a leading experience, engineering, and engagement technology solutions company, announced its addition to Salesforce’s Agentforce 360 for Life Sciences Migration Alliance. This recognition highlights Zensar’s proven technology consulting expertise in pharmaceutical and life science, driving transformations, and positioning companies as a strategic partner for organizations navigating the upgrade to reimagined, AI-driven solutions.
As part of this elite network of global consulting and independent software vendor (ISV) partners with deep life sciences domain knowledge, Zensar is equipped to guide clients through the transformation from legacy systems and the implementation of Agentforce Life Sciences helping companies become Agentic Enterprises. Salesforce’s agentic engagement platform, tailored for pharma, biotech, medtech, and consumer health companies, enables compliant, data-driven engagements across clinical, medical, commercial, and patient services operations. Key features include AI-enabled clinical trial acceleration, intelligent HCP engagement, predictive analytics for facility selection, and automated patient outreach with real-time adverse event management.
Pratik Maroo, Head of Healthcare and Life Sciences, Zensar, said, “Being selected for Salesforce’s Life Sciences Partner Network validates Zensar’s expertise in healthcare innovation and our deep bench in pharma and life sciences. We’re thrilled to be working with Salesforce to empower clients with agentic AI that transforms clinical trials, streamlines commercial operations, and enhances patient outcomes - all while ensuring regulatory compliance in a competitive landscape.”
“We are thrilled to welcome Zensar Technologies to our exclusive Agentforce 360 for Life Sciences Migration Alliance,” said Tara Helm, VP and GM of Commercial, Agentforce Life Sciences at Salesforce. “Zensar's expertise in life sciences and their experience-led approach are a powerful combination with our Agentforce 360 platform. This alliance will accelerate our clients’ digital transformation journey, helping them migrate from legacy systems to our AI-driven CRM, ultimately enhancing patient outcomes through more agentic engagement.”
For Zensar’s clients, this announcement unlocks accelerated digital transformation opportunities. Zensar’s Salesforce partnership in specialized life sciences capabilities addresses pain points like legacy system silos, manual processes, and fragmented customer data. By combining Zensar’s experience-led approach with Agentforce’s unified platform, clients can achieve faster time-to-value, personalized HCP and patient interactions, and scalable AI innovations that drive revenue growth and operational efficiency.
Princeton, February 24, 2026
